Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-159538 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
19,653
Total Value
$815,035.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 4,466 | $30.17 | $134,739.22 | 65,668 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 785 | $43.50 | $34,147.50 | 66,453 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 14, 2026 | Sale | 5,251 | $90.00 | $472,598.40 | 61,202 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Exercise/Conversion | 1,300 | $43.50 | $56,550.00 | 62,502 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 15, 2026 | Sale | 1,300 | $90.00 | $117,000.00 | 61,202 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 4,466 | $0.00 | $0.00 | 45,534 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 785 | $0.00 | $0.00 | 59,763 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 15, 2026 | Exercise/Conversion | 1,300 | $0.00 | $0.00 | 58,463 | Direct | โ | View Details |